Cannabidiol and CES1 Interactions in Healthy Subjects

Phase 4 Completed 14 enrolled University of Florida Consortium for Medical Marijuana Clinical Outcomes Research · collab

RandomizedCrossoverSingle-blindOther

Summary

The proposed study will assess the drug interaction potential between oral cannabidiol (Epidiolex®) and the carboxylesterase 1 (CES1) substrate methylphenidate (Ritalin®) in 12 healthy research subjects

Timeline

Start: 2021-02-25
Primary completion: 2021-12-31
Completion: 2021-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cannabidiol	Other / unclassified	750 mg	Oral
Subject	Methylphenidate	Small molecule	10 mg	Oral

Indications

No indication recorded.